Targeting tryptophan metabolism in cardiovascular disease: From immune-metabolic crosstalk to precision therapy

Haoyuan Hu, Wei Guo, Xinyi Li, Zijing Li, Yourong Chen, Yijing Wang, Kaijia Hu, Ziqiang Chen, Hong Jiang, Songyun Wang

Open source

DOI
10.1016/j.phrs.2026.108429
Published
2026-10
Container
Pharmacological Research
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.phrs.2026.108429,
  title = {Targeting tryptophan metabolism in cardiovascular disease: From immune-metabolic crosstalk to precision therapy},
  author = {Haoyuan Hu and Wei Guo and Xinyi Li and Zijing Li and Yourong Chen and Yijing Wang and Kaijia Hu and Ziqiang Chen and Hong Jiang and Songyun Wang},
  year = {2026},
  journal = {Pharmacological Research},
  doi = {10.1016/j.phrs.2026.108429},
  url = {https://doi.org/10.1016/j.phrs.2026.108429}
}

RIS

TY  - JOUR
TI  - Targeting tryptophan metabolism in cardiovascular disease: From immune-metabolic crosstalk to precision therapy
AU  - Haoyuan Hu
AU  - Wei Guo
AU  - Xinyi Li
AU  - Zijing Li
AU  - Yourong Chen
AU  - Yijing Wang
AU  - Kaijia Hu
AU  - Ziqiang Chen
AU  - Hong Jiang
AU  - Songyun Wang
PY  - 2026
JO  - Pharmacological Research
DO  - 10.1016/j.phrs.2026.108429
UR  - https://doi.org/10.1016/j.phrs.2026.108429
ER  - 

APA

Hu, H., Guo, W., Li, X., Li, Z., Chen, Y., Wang, Y., Hu, K., Chen, Z., Jiang, H., & Wang, S. (2026). Targeting tryptophan metabolism in cardiovascular disease: From immune-metabolic crosstalk to precision therapy. Pharmacological Research. https://doi.org/10.1016/j.phrs.2026.108429

Source records